Member Info for Thompi

I wouldn’t invest now, and for all the reasons ForFXSake outlined really well, and for the same reasons I’m holding.
It would also be preferable to have a CEO who engages with shareholders and investors more, CB is very anonymous.
Fortunately I invested at the same time in a couple of other shares and they have performed well, although I invested the most in NFX. The CEO’s

An Investors Interview, like CB did in July, or something similar would be very welcome to bolster some confidence.

Good counter argument OBW.
Ref Soup, when I initially invested at 7.5p I didn’t expect to see an immediate gain. Nor did I expect to see DT and Dan to go within 6 months and the share price plummet. Confidence and credibility needs to be restored imo.

Good post Kit. Sums up the situation well and highlights the lack of clarity in direction.
Agree with you point 4, and I am holding for the same reasons.
“4. From an investment perspective, its still a hold (I think!) :) mainly due to the product potential and current market conditions- lets see how Q4 plays out. Criteria:
- Product - Excellent - Potentially world class, especially 002
- Market Conditions - Excellent- In the current climate, there is/would be serious demand for this type of drug
- Finance Structure / Cash Burn - Average/Ok - Two placings in less than 12 months. not great
- Management - Poor - Many changes in Board, significant milestones not met - YET!”

Hi Soup, but have we got anything tangible to show for it?
I have invested good money and followed it up with more, I want this company to do well. Our last podcast was in July. I think CB is overdue another one to reassure investors their money is being well spent.

Very underwhelmed. I’m massively in the red. Haven’t got much faith in the board anymore. Not sure I want to commit more funds without more detail.

To be clear, this is not directed at any individual poster. Let us all stick to the subject and not get personal or political.

This is not a political site. Stick to the point, which is NFX.

Nice one Brooko, I heard your question and liked the answer.

With the potential sale of Imutex and the interest in wearables it sounds as though a lot of good news is on the way before Christmas.

HL are very frustrating, and their limit buys & sells aren’t reliable either.

I’m stuck with them for the time being because I don’t want to be out of the market for any length of time. I have my SIPP with them.

Hope you managed to eventually make your trade at the price you wanted.

Thanks Barwickman, and apologies all about being a plank about the wearables. I always read the RNS’s but obviously not all the way to the bottom!
Cracking company, looking forward to Cathal’s next presentation.

And in the Notes to Editors more about wearables -
“ hVIVO has built up one of the world's largest databases of infectious disease progression data and we are populating our Open Orphan Health Data platform with this historical hVIVO data. In our clinical trials going forward, we are also planning to collect data on volunteer's via wearables during clinical trials. Therefore, Open Orphan's data, which may yield valuable digital biomarkers, could be one of the more sought-after datasets by many of the large wearables /smart watch wearables providers around the world.

Flipping heck, finally an RNS. Thanks Chab for the VOX tip, it’s very helpful to have an alert message.
It’s going to be an interesting day.

I can buy ORPH this afternoon but not sell, “unable to retrieve a live quote” message again.
I hadn’t wanted to make a trade, but I did want to test HL, as they have lost me the opportunity to lock in a profit on a previous occasion and they are losing credibility. Still looking for a reliable alternative.

Good to see a new “non-COVID” contract for Venn. An oncology study expected to enrol over 750 subjects, shows we are a very multidimensional company.
No financial detail.

Yes, Raj, it could just be the markets generally spooked, buy I have had difficulties trading ORPH with HL on a quiet day.
Frustrating, I only wanted to sell a small amount to lock in some profit, and that moment has well and truly gone.
Great stock though, so an annoyance, but not a major problem.

Unable to trade with HL again “unable to retrieve a live quote”. HL is one one of the biggest UK-based stockbrokers and it is very frustrating to be restricted on trading.
I am emailing a complaint.

Good point Lochinvar about checking the spreads. Not sure, to be honest, though on how to compare them on different platforms.

Thanks AquaeSulis01 for the HL post. I haven’t complained, but will do if the problems persist.

I’ve had difficulty trading with HL too, ended up going through a broker last week.
Added some more shares through HL in my SIPP on Wednesday, but had to cancel my buy limit with them as the shares were trading lower than the price I had set and it hadn’t activated. Bought at a lower price from a “real” time quote. Guess setting limits is never foolproof.